Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Wells Messersmith to Drug Discovery

This is a "connection" page, showing publications Wells Messersmith has written about Drug Discovery.

 
Connection Strength
 
 
 
0.233
 
  1. Bagby S, Messersmith WA, Pitts TM, Capasso A, Varella-Garcia M, Klauck PJ, Kim J, Tan AC, Eckhardt SG, Tentler JJ, Arcaroli J. Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies. J Vis Exp. 2016 09 30; (115).
    View in: PubMed
    Score: 0.123
  2. Thompson C, Leong S, Messersmith W. Promising targets and drugs in development for colorectal cancer. Semin Oncol. 2011 Aug; 38(4):588-97.
    View in: PubMed
    Score: 0.086
  3. Davis SL, Eckhardt SG, Messersmith WA, Jimeno A. The development of regorafenib and its current and potential future role in cancer therapy. Drugs Today (Barc). 2013 Feb; 49(2):105-15.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)